Result of General Meeting

Summary by AI BETAClose X

MedPal AI plc announced that all resolutions were passed at its General Meeting, leading to the issuance of warrants to Clear Capital. These warrants include 5,000,000 at an 8p exercise price expiring in October 2030, 7,480,242 at 5.01p expiring in March 2029, and 1,570,000 at 2.5p expiring in March 2031, totaling 14,050,242 warrants.

Disclaimer*

Medpal AI PLC
29 October 2026
 

29 October 2026

MedPal AI plc

("MedPal", the "Company" or the "Group")

Result of General Meeting

Issue of Warrants

 

Further to its announcement of 6 October 2026, MedPal AI plc (AIM: MPAL; FRA: Z1N), the AI-native digital health and pharmacy group, announces that announces that at the General Meeting of the Company held earlier today, all resolutions were duly passed. Accordingly, the Company has issued warrants to Clear Capital in relation to historical fundraises as shown below:

Number of Warrants

Exercise Price

Exercise Period

5,000,000

8p

the period ending on 8 October 2030

7,480,242

5.01p

the period ending on 3 March 2029

1,570,000

2.5p

the period ending on 26 March 2031

14,050,242

-

 

 

 

For further information please contact:

Enquiries:

MedPal AI plc

Jason Drummond, Chief Executive Officer

Via Square1 Consulting

Cairn Financial Advisers LLP (Nomad)

Louise O'Driscoll / Jo Turner

+44 (0) 20 7213 0880

Merlin Partners LLP (Broker)

 

+44 (0) 20 7839 3500

Clear Capital Markets Limited (Broker)

Bob Roberts

+44 (0) 20 3869 6080

Square1 Consulting - (Financial PR)

David Bick

+44 (0) 20 7929 5599 / +44 (0) 7831 381201

 

 

 

 

About MedPal AI plc

MedPal AI plc (AIM: MPAL; FRA: Z1N) is a vertically integrated, AI-native digital health and pharmacy group. The Group operates NHS Distance Selling Pharmacy hubs at Sarus Court, Runcorn and Swaffham, New Health (new.co.uk), a dedicated GLP-1 weight management clinic, a B2B care home pharmacy supply business, eMARx, the Group's electronic medication administration record software for care homes, and Juno, an agentic AI health companion built on Anthropic's Claude. MedPal's ambition is to build the UK's leading Health OS: a single platform connecting prescribing, dispensing, delivery, administration and AI-driven patient support. The Company's LEI is 984500EDP8B0A14CBA61.

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Medpal AI PLC (MPAL)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today